Postexposure Treatment of Marburg Virus Infection

被引：66

作者：

Geisbert, Thomas W. ^{[1
]}

Hensley, Lisa E. ^{[2
]}

Geisbert, Joan B.

Leung, Anders ^{[3
]}

Johnson, Joshua C. ^{[2
]}

Grolla, Allen ^{[3
]}

Feldmann, Heinz ^{[4
]}

机构：

[1] Boston Univ, Sch Med, Natl Emerging Infect Dis Labs Inst, Boston, MA 02118 USA

[2] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA

[3] Publ Hlth Agcy Canada, Winnipeg, MB, Canada

[4] NIH, Hamilton, MT USA

来源：

EMERGING INFECTIOUS DISEASES | 2010年 / 16卷 / 07期

基金：

美国国家卫生研究院;

关键词：

EBOLA HEMORRHAGIC-FEVER; NONHUMAN-PRIMATES; PROTECTION; VECTORS;

D O I：

10.3201/eid1607.100159

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Rhesus monkeys are protected from disease when a recombinant vesicular stomatitis virus-based vaccine is administered 20-30 min after infection with Marburg virus. We protected 5/6 monkeys when this vaccine was given 24 h after challenge; 2/6 animals were protected when the vaccine was administered 48 h postinfection.

引用

页码：1119 / 1122

页数：4

共 14 条

[11] Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit [J].

Kortepeter, Mark G. ;

Martin, James W. ;

Rusnak, Janice M. ;

Cieslak, Theodore J. ;

Warfield, Kelly L. ;

Anderson, Edwin L. ;

Ranadive, Manmohan V. .

EMERGING INFECTIOUS DISEASES, 2008, 14 (06) :881-887

[12]

Sanchez A, 2006, FIELDS VIROLOGY, P1409

[13] Experimental vaccine may have saved Hamburg scientist from Ebola fever [J].

Tuffs, Annette .

BRITISH MEDICAL JOURNAL, 2009, 338

[14]

Warfield Kelly L., 2006, PLoS Pathogens, V2, P5

← 1 2 →